Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Yaupon Therapeutics Completes Patient Enrollment For Pivotal Phase 2 Study Of Clearazide For Treatment Of Cutaneous T-cell Lymphoma
Yaupon Therapeutics, a privately held specialty pharmaceutical company, has announced it has completed enrollment for a pivotal Phase 2 clinical trial for Clearazide for the treatment of early-stage cutaneous T-cell lymphoma (CTCL - stages 1-2a). The study, which is being conducted under a Special Protocol Assessment (SPA) with the FDA, has enrolled 260 patients in 13 of the top cancer centers in the US. Yaupon expects the last patient to complete treatment in the study by June of 2010 and, assuming positive results, will file its NDA shortly thereafter.
generic viagra online
Groups Mark Day Of The African Child, Highlight Improvement In Children's Survival, Work To Be Done
To mark Day of the African Child on Tuesday, the U.N. Millennium Campaign is calling on African governments, civil society organizations and the private sector to address child and maternal mortality and other targets related to the U.N. Millennium Development Goals (MDGs), InDepthNews reports (Mwanda, InDepthNews, 6/16), while Save the Children released a new briefing paper, indicating that more than 1,500 babies born in sub-Saharan Africa die daily, "mostly from preventable or treatable causes," (Save the Children release, 6/16).
News of the day
Regulation Must Be Extended To Help Stamp Out Abuse, UK
Patients will continue to be unprotected if statutory independent regulation is not extended to counsellors and psychotherapists, according to leading national charities Mind and WITNESS. On the day that psychologists are to be regulated by the Health Professions Council (HPC), the charities welcome the advancement and urge counsellors and psychotherapists to follow suit.
Public Health

New Booklet Helps Patients Better Understand Radiation Therapy

The American Society for Radiation Oncology (ASTRO) has recently updated its award-winning patient booklet, Radiation Therapy for Cancer that provides information for people living with cancer and their loved ones who are exploring radiation therapy as a treatment option. The 24-page booklet provides information for patients on the various types of radiation therapy techniques, such as brachytherapy and external beam treatments. It also helps patients understand the various types of external beam treatments, including three-dimensional conformal radiation therapy (3D-CRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), stereotactic body radiation therapy (or stereotactic radiosurgery), proton therapy and neutron beam therapy. Information on clinical trials and side effects are also included as well as a list of questions patients may want to ask their doctors as they consider their treatment options. "Trying to make sense of the various cancer treatments can be a real challenge when coping with a diagnosis of cancer. Our hope is that this booklet will help patients and their families better understand how the treatments work so they can make the best decisions about their treatments," said Gregory Patton, M.D., chair of ASTRO"s Communications Committee and a radiation oncologist at Northwest Cancer Specialists, P.C., in Portland, Ore. ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy. For more information on radiation therapy, visit http://www.rtanswers.org. To learn more about ASTRO, visit http://www.astro.org. ASTRO


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009